Jiangsu Bioperfectus Technologies Co., Ltd. — Investor Relations & Filings
About Jiangsu Bioperfectus Technologies Co., Ltd.
Jiangsu Bioperfectus Technologies Co., Ltd. specializes in the research, development, and manufacturing of molecular diagnostic solutions. The company provides a comprehensive portfolio of products, including real-time PCR diagnostic kits, automated nucleic acid extraction systems, and rapid test reagents. Its primary focus lies in the detection of infectious diseases, such as respiratory infections, sexually transmitted diseases, and vector-borne illnesses. Bioperfectus serves clinical laboratories, public health institutions, and research facilities. The company provides integrated laboratory workflows designed to enhance diagnostic efficiency and accuracy. Key product lines include solutions for HPV screening, influenza monitoring, and emerging pathogen detection, supported by high-throughput diagnostic platforms.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 江苏硕世生物科技股份有限公司董事会审计委员会工作细则 | 2025-10-24 | Chinese | |
| 江苏硕世生物科技股份有限公司关于变更注册资本、取消监事会并修订《公司章程》及修订、制定相关内部治理制度的公告 | 2025-10-24 | Chinese | |
| 江苏硕世生物科技股份有限公司关于召开2025年第二次临时股东大会的通知 | 2025-10-24 | Chinese | |
| 江苏硕世生物科技股份有限公司内部审计制度 | 2025-10-24 | Chinese | |
| 江苏硕世生物科技股份有限公司重大信息内部保密制度 | 2025-10-24 | Chinese | |
| 江苏硕世生物科技股份有限公司董事会议事规则 | 2025-10-24 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 39091082 | 江苏硕世生物科技股份有限公司董事会审计委员会工作细则 | 2025-10-24 | Chinese | ||
| 39091078 | 江苏硕世生物科技股份有限公司关于变更注册资本、取消监事会并修订《公司章程》及修订、制定相关内部治理制度的公告 | 2025-10-24 | Chinese | ||
| 39091075 | 江苏硕世生物科技股份有限公司关于召开2025年第二次临时股东大会的通知 | 2025-10-24 | Chinese | ||
| 39091067 | 江苏硕世生物科技股份有限公司内部审计制度 | 2025-10-24 | Chinese | ||
| 39091059 | 江苏硕世生物科技股份有限公司重大信息内部保密制度 | 2025-10-24 | Chinese | ||
| 39091054 | 江苏硕世生物科技股份有限公司董事会议事规则 | 2025-10-24 | Chinese | ||
| 39091045 | 江苏硕世生物科技股份有限公司董事会审计委员会年报工作制度 | 2025-10-24 | Chinese | ||
| 39091033 | 江苏硕世生物科技股份有限公司对外捐赠管理制度 | 2025-10-24 | Chinese | ||
| 39091028 | 江苏硕世生物科技股份有限公司对外担保管理制度 | 2025-10-24 | Chinese | ||
| 39091021 | 江苏硕世生物科技股份有限公司关于2025年前三季度计提及转回资产减值准备的公告 | 2025-10-24 | Chinese | ||
| 39091011 | 江苏硕世生物科技股份有限公司关于2025年度对外捐赠额度预计的公告 | 2025-10-24 | Chinese | ||
| 39091002 | 江苏硕世生物科技股份有限公司关于聘任副总经理的公告 | 2025-10-24 | Chinese | ||
| 39090996 | 江苏硕世生物科技股份有限公司第三届监事会第十一次会议决议的公告 | 2025-10-24 | Chinese | ||
| 39090990 | 江苏硕世生物科技股份有限公司信息披露暂缓与豁免事务管理制度 | 2025-10-24 | Chinese | ||
| 39090979 | 江苏硕世生物科技股份有限公司重大信息内部报告制度 | 2025-10-24 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Jiangsu Bioperfectus Technologies Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/58400/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=58400 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=58400 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=58400 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 58400}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Jiangsu Bioperfectus Technologies Co., Ltd. (id: 58400)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.